文献速递外周动脉疾病

慢性肢体威胁性缺血血运重建后性别相关死亡率的变化:1994至2018年全国观察性研究

Changes in Sex Related Mortality after Revascularisation for Chronic Limb Threatening Ischaemia: A National Observational Study 1994 - 2018.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2024-09-03

该观察性登记研究比较瑞典1994至2013年间因慢性肢体威胁性缺血行膝下开放或腔内血运重建患者三个时间段的性别差异全因死亡率。结果显示女性每时间段30天死亡调整相对风险比aRR为1.47,男性为1.20;女性五年调整限制性平均生存时间每时间段减少45天,男性增加32天。

要点

  • 女性每时间段30天死亡aRR为1.47(95%CI 1.31-1.65),男性为1.20(95%CI 1.06-1.35)。
  • 女性五年aRMST每时间段为-45天(95%CI -59至-32),男性为32天(95%CI 18-47)。
  • 第一时期女性30天死亡率低于男性且五年生存率高于男性,但随时间恶化较男性更显著。

核心结论

  • 研究显示女性和男性30天死亡率随时间段增加,女性更明显;男性五年生存率随时间改善,女性则相反;女性不良趋势不能用年龄增加或合并症更常见解释。

研究设计与样本

  • 观察性登记研究,纳入瑞典血管登记库(Swedvasc)1994至2013年间行膝下开放或腔内血运重建的患者,分为1994-1999、2000-2006和2007-2013三个时间段,随访五年。

主要发现

  • 女性每时间段30天死亡aRR为1.47(95%CI 1.31-1.65),男性aRR为1.20(95%CI 1.06-1.35)。
  • 女性五年aRMST每时间段为-45天(95%CI -59至-32),男性为32天(95%CI 18-47)。
  • 第一时期女性30天死亡率低于男性且五年生存率高于男性,但随时间恶化较男性更显著。
  • 与瑞典一般人群比较观察到相应结果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to compare all cause mortality across three time periods with a focus on sex differences after revascularisation for chronic limb threatening ischaemia between 1994 and 2013 in Sweden. METHODS: In this observational registry study, patients registered in the Swedish vascular registry (Swedvasc), revascularised between 1994 and 2013 with open or endovascular infra-inguinal procedures, were divided into three time periods: 1994 - 1999, 2000 - 2006, and 2007 - 2013. Patients were followed for five years. Poisson regression was used to compare 30 day mortality, presented as adjusted relative risk ratio (aRR). Adjusted restricted mean survival time (aRMST) differences at five years were compared with a generalised linear model. The analyses were adjusted for age, comorbidities, and endovascular or open surgery. Comparison with the general Swedish population was also conducted with age adjusted standardised mortality ratios. Results are presented with the 95% confidence interval (CI). RESULTS: The study showed increasing 30 day mortality, with an aRR of 1.47 (95% CI 1.31 - 1.65) for women and aRR of 1.20 (95% CI 1.06 - 1.35) for men, per time period. In women, the five year RMST decreased from the first to the third period, with an aRMST of -45 (95% CI -59 - -32) days per period. In men, the aRMST increased 32 (95% CI 18 - 47) days per period. When comparing sexes, women showed lower 30 day mortality and higher five year survival than men in the first time period, but a significantly worse development over time periods than for men. Corresponding findings were observed in comparison with the general Swedish population. CONCLUSION: This study showed an increased 30 day mortality in women and men across the periods, most evident in women. Men showed an increased five year survival across the periods, whereas opposite findings were recorded for women. The dismal trend over time for women could not be explained by increased age or a higher prevalence of comorbidities.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Skoog P, Larsson H, Magnuson A, et al. Changes in Sex Related Mortality after Revascularisation for Chronic Limb Threatening Ischaemia: A National Observational Study 1994 - 2018. Eur J Vasc Endovasc Surg. 2024. PMID: 39237054. doi:10.1016/j.ejvs.2024.08.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。